Striving for a Cure for Pediatric Cancers
It is one of the worst pronouncements a person can hear from a doctor — that you’ve got cancer — now imagine that diagnosis is for a child. "PCF has been instrumental in providing critical grant support over the past quarter of a century to help raise the cure rate in pediatric cancer from approximately 50-60 percent to 85-90 percent today," says Dr. Mitchell S. Cairo, Chief of Pediatric Hematology, Oncology and Stem Cell Transplantation at Maria Fareri. The group has raised more than $500,000 towards research for hospitals that include Maria Fareri, New York-Presbyterian Morgan Stanley Children’s Hospital, Stephen D. Hassenfeld Children’s Center for Cancer at NYU Langone Medical Center, Memorial Sloan-Kettering Cancer Center, Feinstein Institute of Medical Research Northwell Health and University of Chicago Medicine Comer Children’s Hospital. Dr. Cairo describes PCF as instrumental in providing millions of dollars in critical grant support to raise the cure rate. "Major accomplishments over the past 40 years have occurred in pediatric(cancers)," says Cairo. ALL, NHL, HL, Wilms Tumor among others." He cites emotional support for family members as another important factor in the process.
NYMC Faculty: Mitchell S. Cairo, M.D., professor of pediatrics, medicine, pathology, microbiology and immunology, and cell biology and anatomy